Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Kucharzik

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Inflammatory Bowel Diseases|January 17, 2017
Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter StudyTorsten Kucharzik, Gunter Lemmnitz, Christoph Abels, et al.
Infection and Immunity|September 22, 2006
Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?Jan Heidemann, Wolfram Domschke, Torsten Kucharzik, et al.
Journal of Crohn'S & Colitis|May 20, 2024
Intestinal Ultrasound-Ready to Use for Early Prediction of Disease Course in IBD?Dana Duricova, Torsten Kucharzik, Katarina Mitrova, et al.
Annals of the New York Academy of Sciences|October 24, 2006
Apoptosis as a therapeutic tool in IBD?Andreas Lügering, Pia Lebiedz, Stefan Koch, et al.
Zeitschrift Fur Gastroenterologie|June 16, 2025
From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitisElisabeth Schnoy, Axel Dignass, Matthew Gaskins, et al.
Zeitschrift Fur Gastroenterologie|March 13, 2026
Correction: From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitisElisabeth Schnoy, Axel Dignass, Matthew Gaskins, et al.
Deutsches Arzteblatt International|November 5, 2020
Ulcerative Colitis-Diagnostic and Therapeutic AlgorithmsTorsten Kucharzik, Sibylle Koletzko, Klaus Kannengiesser, et al.
Zeitschrift Fur Gastroenterologie|December 8, 2020
Petra Lynen, Axel Dignaß, Torsten Kucharzik, et al.
Zeitschrift Fur Gastroenterologie|June 22, 2026
[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care]Irina Blumenstein, Axel Dignass, Torsten Kucharzik, et al.
Zeitschrift Fur Gastroenterologie|May 8, 2024
Pia Lorenz, Axel Dignass, Torsten Kucharzik, et al.
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Inflammatory Bowel Diseases|January 17, 2017
Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter StudyTorsten Kucharzik, Gunter Lemmnitz, Christoph Abels, et al.
Infection and Immunity|September 22, 2006
Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?Jan Heidemann, Wolfram Domschke, Torsten Kucharzik, et al.
Journal of Crohn'S & Colitis|May 20, 2024
Intestinal Ultrasound-Ready to Use for Early Prediction of Disease Course in IBD?Dana Duricova, Torsten Kucharzik, Katarina Mitrova, et al.
Annals of the New York Academy of Sciences|October 24, 2006
Apoptosis as a therapeutic tool in IBD?Andreas Lügering, Pia Lebiedz, Stefan Koch, et al.
Zeitschrift Fur Gastroenterologie|June 16, 2025
From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitisElisabeth Schnoy, Axel Dignass, Matthew Gaskins, et al.
Zeitschrift Fur Gastroenterologie|March 13, 2026
Correction: From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitisElisabeth Schnoy, Axel Dignass, Matthew Gaskins, et al.
Deutsches Arzteblatt International|November 5, 2020
Ulcerative Colitis-Diagnostic and Therapeutic AlgorithmsTorsten Kucharzik, Sibylle Koletzko, Klaus Kannengiesser, et al.
Zeitschrift Fur Gastroenterologie|December 8, 2020
Petra Lynen, Axel Dignaß, Torsten Kucharzik, et al.
Zeitschrift Fur Gastroenterologie|June 22, 2026
[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care]Irina Blumenstein, Axel Dignass, Torsten Kucharzik, et al.
Zeitschrift Fur Gastroenterologie|May 8, 2024
Pia Lorenz, Axel Dignass, Torsten Kucharzik, et al.
Pageof 16